Kalaris Therapeutics, Inc. (KLRS)

Kalaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	88.43	1.64	90.12	106.09	201.66	122.66
Short-Term Investments	-	-	93.82	127.7	46.46	233.66
Cash & Short-Term Investments	88.43	1.64	183.94	233.8	248.12	356.32
Cash Growth	-31.78%	-99.11%	-21.32%	-5.77%	-30.37%	182.62%
Other Receivables	-	-	0.21	0.16	0.05	0.45
Total Trade Receivables	-	-	0.21	0.16	0.05	0.45
Other Current Assets	3.23	0.97	3.49	9.1	5.18	4.54
Total Current Assets	91.65	2.61	187.64	243.05	253.35	361.32
Net Property, Plant & Equipment	-	-	2.19	32.56	31.29	9.5
Other Long-Term Assets	1.19	3.56	0.97	1.46	1.95	-
Total Assets	92.84	6.16	190.8	277.08	286.59	370.82
Accounts Payable	3.68	1.56	6.76	3	8.36	0.96
Accrued Expenses	3.97	2.2	10.09	13.99	20.15	7.53
Short-Term Debt	-	19.54	-	-	-	-
Current Portion of Leases	-	-	10.78	7.17	6.59	3.23
Other Current Liabilities	-	1.41	0.74	0.18	2.75	0.57
Total Current Liabilities	7.65	24.7	28.37	24.34	37.85	12.29
Long-Term Leases	-	-	16.65	28.22	23.48	5.46
Other Long-Term Liabilities	32.08	32.08	-	-	-	-
Total Long-Term Liabilities	32.08	32.08	16.65	28.22	23.48	5.46
Total Liabilities	39.73	56.78	45.02	52.56	61.33	17.76
Common Stock	0	-	-	0.01	0.01	0.01
Additional Paid-in Capital	191.22	19.95	802.04	690.75	522.48	478.27
Accumulated Other Comprehensive Income	-	-	-0.06	-0.47	-0.16	-0.11
Retained Earnings	-138.11	-116.56	-656.19	-465.78	-297.07	-125.1
Total Common Shareholders' Equity	53.12	-96.62	145.78	224.52	225.27	353.06
Minority Interest	-	46	-	-	-	-
Shareholders' Equity	53.12	-50.62	145.78	224.52	225.27	353.06
Total Liabilities & Equity	92.84	6.16	190.8	277.08	286.59	370.82
Total Debt	0	19.54	27.43	35.39	30.07	8.69
Net Cash (Debt)	88.43	-17.9	156.51	198.41	218.05	347.63
Net Cash Growth	-	-	-21.12%	-9.01%	-37.27%	204.09%
Net Cash Per Share	1.92	-3.57	34.59	2.59	3.47	12.92
Book Value	53.12	-96.62	145.78	224.52	225.27	353.06
Book Value Per Share	1.15	-19.29	32.22	2.93	3.59	13.13
Tangible Book Value	53.12	-96.62	145.78	224.52	225.27	353.06
Tangible Book Value Per Share	1.15	-19.29	32.22	2.93	3.59	13.13

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q